Last Wednesday we had the pleasure of hearing from Matt Scholz, CEO of the biotech startup, Immusoft. He is pursuing a revolutionary science that will turn a person’s B-Cells into, “drug factories.” Thank you to all of you who came to the meeting. Check out the link to Immusoft’s website below if you want to learn more about the company. There is also a lot of very interesting media coverage of their work.